## AME: AMETEK, Inc. - XLI: Industrials

### Executive Summary

No thesis match: MRS_20 -0.0% below STRENGTH zone (4.0-10.0%); PEG 2.81 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($192.76)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 9
- **Sentiment:** Bullish (Bullish: 4, Bearish: 0)

**1. Barclays Reaffirms Their Hold Rating on Ametek (AME)**
- Source: The Globe and Mail | 20251205T200825 | Neutral | Relevance: 100%
- Barclays analyst Julian Mitchell maintained a Hold rating on Ametek (AME) with a $205.00 price target. This comes after Ametek reported strong quarterly revenues of $1.89 billion and net profit of $371.42 million, an increase from the previous year. Despite positive earnings, corporate insider sentiment on the stock is negative due to increased insider selling.

**2. Is AMETEK Stock Underperforming the Dow?**
- Source: Palmetto Grain Brokerage | 20251204T200741 | Bullish | Relevance: 100%
- AMETEK, Inc. (AME) is a large-cap stock in the industrial sector with a market cap of $45.4 billion. While AME stock has gained 8.1% over the past three months, outperforming the Dow, it has underperformed the broader market over the longer term with 10.5% YTD gains compared to the Dow's 12.6% surge. Despite prior underperformance, AMETEK's Q3 results were strong, leading to a 7.7% stock price jump and a "Moderate Buy" consensus rating from analysts with significant upside potential.

**3. A Closer Look at AMETEK (AME) Valuation After Strong Q3 Growth and Margin Expansion**
- Source: Simply Wall Street | 20251204T073442 | Bullish | Relevance: 100%
- AMETEK (AME) experienced a significant 7.7% stock jump after its strong Q3 earnings release, driven by double-digit growth in sales, orders, and earnings, alongside improved margins. While a narrative fair value suggests the stock is 9.4% undervalued, a discounted cash flow (DCF) model indicates it might be overvalued, presenting differing perspectives on its true intrinsic value. The article encourages investors to explore these different valuation angles and consider potential risks and growth factors.

**4. A Closer Look at AMETEK (AME) Valuation After Strong Q3 Growth and Margin Expansion**
- Source: Simply Wall Street | 20251204T072557 | Bullish | Relevance: 100%
- AMETEK (AME) experienced a 7.7% stock jump after strong Q3 results, showing double-digit growth in sales, orders, earnings, and improved margins. While Simply Wall St's narrative valuation suggests the stock is 9.4% undervalued with a fair value of $219.94, their DCF model indicates it might be overvalued at its current price compared to an intrinsic value near $151.97. The article encourages investors to analyze both perspectives and consider risks, such as semiconductor demand weakness or M&A integration challenges.

**5. Maren Capital LLC Purchases 44,098 Shares of AMETEK, Inc. $AME**
- Source: MarketBeat | 20251204T122217 | Somewhat-Bullish | Relevance: 100%
- Maren Capital LLC increased its stake in AMETEK, Inc. by 5.8% during the second quarter, purchasing 44,098 additional shares and bringing its total holdings to 804,473 shares valued at approximately $145.6 million. This makes AMETEK the firm's 5th largest holding, representing 8.8% of its portfolio. AMETEK recently reported strong Q3 earnings, beating analyst estimates, and has received a "Moderate Buy" rating from analysts with an average price target of $211.00, despite some insider selling by CEO David A. Zapico.

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 1 ($0.91M) |
| Sells | 4 ($7.72M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 42.0% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- Vanguard Group Inc: 11.8% (+0.6%)
- Blackrock Inc.: 8.5% (-0.9%)
- Price (T.Rowe) Assoc: 4.3% (-7.3%)
- State Street Corpora: 4.2% (+1.3%)
- JPMORGAN CHASE & CO: 3.6% (+77.0%)

### Key Risks

1. Insider selling cluster: $7.7M in recent transactions.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 2.81 signals overvaluation risk, limited margin of safety. Forward P/E 25.0x stretched relative to 8% growth. Quality metrics strong (margin 20%). Insider selling cluster ($7.7M in 90 days), potential headwind. Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $48.1B |
| Beta | 1.05 |
| 52W Range | $145.02 - $210.14 |
| Short Interest | 1.3% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.81 |
| Forward P/E | 25.0 |
| Current P/E | 27.1 |
| YoY Growth | 8.4% |
| EPS Direction | STABLE |

### Technicals

MRS_20 improving modestly (+0.9% over 5 days). Below STRENGTH zone by 4.0pp (needs >4.0% for momentum thesis). MRS_5 turning positive (0.3%) - potential reversal signal. Full SMA alignment bullish (above 20/50/200 SMAs). OFD pattern: +SUN (Resistance test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -0.01% (CS: 53) | Neutral |
| RSI_14 | 61.5 | Neutral |
| MACD Histogram | 0.30 | Bullish |
| vs SMA20 | 1.022x | Above |
| vs SMA50 | 1.046x | Above |
| vs SMA200 | 1.101x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $199.80
- **Stop Loss:** $192.76 (3.5% risk)
- **Target:** $206.84 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 170
- **Position Value:** $33,966.00
- **Portfolio %:** 33.97%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 100% | L2 120% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | IGNITION (Zone D) | 1.20x |

*NORMAL regime with balanced risk appetite. VIX near 15th percentile of 52-week range signals calm conditions, while modest yield curve steepening (54bps 10Y-3M) suggests healthy growth expectations. Breadth at 52% indicates selective participation rather than broad-based momentum.*

### Earnings

**Next:** 2026-02-03 (Est: $1.94)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.76 | $1.89 | +7.4% |
| 2025Q2 | $1.69 | $1.78 | +5.5% |
| 2025Q1 | $1.69 | $1.75 | +3.5% |
| 2024Q4 | $1.85 | $1.87 | +1.1% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_20*